Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dallas Imbimbo | M | 39 | 14 years | |
| Pedro Lichtinger | M | 70 |
ChemioCare, Inc.
 ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY.
Starton Therapeutics, Inc.
 Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | 7 years |
| Nicholas Kovacevich | M | 39 | 12 years | |
| David Kaufman | M | - | 26 years | |
| Nitin Kaushal | M | 58 |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | 6 years |
| Barbara Goodstein | F | 63 |
Bgood LLC
| 7 years |
| Cidnee Vaykovich | F | - |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | 7 years |
| Rapp Alyssa | F | 45 | - | |
| Moses Dodo | M | 65 |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | 2 years |
| Fotios Plakogiannis | M | 90 |
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY.
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | - |
| andrew keenam | M | - | 2 years | |
| Roy F. Waldron | M | 61 |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | 5 years |
| Scott Cannon | M | - | 7 years | |
| Sheldon Malchicoff | M | - |
Data Exchange Corp.
 Data Exchange Corp. Miscellaneous Commercial ServicesCommercial Services Data Exchange Corp. provides supply chain solutions for high tech industries. It offers warehousing & distribution, reverse logistics, advanced exchange, procurement services, depot repair, and asset recovery program. The company was founded in 1980 by Sheldon Malchicoff and is headquartered in Camarillo, CA | 44 years |
| Bruno Baillavoine | M | 71 |
ESGAI Technologies, Inc.
| 2 years |
| Anthony Gordon Harris | M | 71 |
Data Exchange Corp.
Data Exchange Corp. Miscellaneous Commercial ServicesCommercial Services Data Exchange Corp. provides supply chain solutions for high tech industries. It offers warehousing & distribution, reverse logistics, advanced exchange, procurement services, depot repair, and asset recovery program. The company was founded in 1980 by Sheldon Malchicoff and is headquartered in Camarillo, CA | - |
| JUSTIN ANDERSON | M | - | 15 years | |
| George Klein | M | - | 10 years | |
| David Kaufman | M | - | 36 years | |
| George Hornig | M | 69 | - | |
| Keith Kleinmaier | M | - | 9 years | |
| Michael Kelly | M | - | 9 years | |
| Nicholas Miller | M | - |
ESGAI Technologies, Inc.
| - |
| Mohamad Hussein | M | - |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | - |
| Justin Fink | M | - | - | |
| Scott Meyer | M | - | - | |
| Roy Waldon | M | - |
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | - |
| Steven Jay Goldman | M | 64 |
Data Exchange Corp.
Data Exchange Corp. Miscellaneous Commercial ServicesCommercial Services Data Exchange Corp. provides supply chain solutions for high tech industries. It offers warehousing & distribution, reverse logistics, advanced exchange, procurement services, depot repair, and asset recovery program. The company was founded in 1980 by Sheldon Malchicoff and is headquartered in Camarillo, CA | - |
| Joanna Sears | F | - | - | |
| Jeff Berk | M | - | 6 years | |
| Amy Rose Dobson | F | 47 | - | |
| Scott Kahn | M | 62 | - | |
| Michael Simon | M | - | 2 years | |
| Eric Baum | M | 37 | 18 years | |
| James Oliver | M | 68 | - | |
| Roman Rogol | M | - |
ChemioCare, Inc.
ChemioCare, Inc. Pharmaceuticals: MajorHealth Technology ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY. | - |
| Reid Rutherford | M | - | 10 years | |
| Michael J. Dean | M | - | - | |
| Benjamin Hom | M | - | - | |
| John MacCarthy | M | 64 | - | |
| Susan Sobbott | F | 59 |
Bgood LLC
| 4 years |
| Blair Naughty | M | - |
ESGAI Technologies, Inc.
| - |
| Susan Rose Hopley | F | 75 | - | |
| Thomas J. Lawley | M | 77 |
Emory University
| 28 years |
| David Sackman | M | - |
Data Exchange Corp.
Data Exchange Corp. Miscellaneous Commercial ServicesCommercial Services Data Exchange Corp. provides supply chain solutions for high tech industries. It offers warehousing & distribution, reverse logistics, advanced exchange, procurement services, depot repair, and asset recovery program. The company was founded in 1980 by Sheldon Malchicoff and is headquartered in Camarillo, CA | - |
| Jerome Kohnke | M | - |
Data Exchange Corp.
Data Exchange Corp. Miscellaneous Commercial ServicesCommercial Services Data Exchange Corp. provides supply chain solutions for high tech industries. It offers warehousing & distribution, reverse logistics, advanced exchange, procurement services, depot repair, and asset recovery program. The company was founded in 1980 by Sheldon Malchicoff and is headquartered in Camarillo, CA | - |
| Kenneth Anderson | M | 72 |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | 4 years |
| Keith Holmes | M | - | 10 years | |
| Michael Riedl | M | 49 |
ESGAI Technologies, Inc.
| 1 years |
| Dale Cohen | M | - |
Data Exchange Corp.
Data Exchange Corp. Miscellaneous Commercial ServicesCommercial Services Data Exchange Corp. provides supply chain solutions for high tech industries. It offers warehousing & distribution, reverse logistics, advanced exchange, procurement services, depot repair, and asset recovery program. The company was founded in 1980 by Sheldon Malchicoff and is headquartered in Camarillo, CA | - |
| Jeffrey R. Haines | M | - |
Data Exchange Corp.
Data Exchange Corp. Miscellaneous Commercial ServicesCommercial Services Data Exchange Corp. provides supply chain solutions for high tech industries. It offers warehousing & distribution, reverse logistics, advanced exchange, procurement services, depot repair, and asset recovery program. The company was founded in 1980 by Sheldon Malchicoff and is headquartered in Camarillo, CA | - |
| Asher Chanan-Khan | M | 55 |
Starton Therapeutics, Inc.
Starton Therapeutics, Inc. BiotechnologyHealth Technology Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017. | - |
| Chilton Varner | F | 81 |
Emory University
| 29 years |
| Jennifer H. Leuer | F | 50 | 5 years | |
| Eric Anderson | M | - | 5 years | |
| Steve Dupuis | M | - | - | |
| Andrew Rensink | M | 68 | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Francis Knuettel | M | 58 | 2 years | |
| Chris McLeod | M | 63 |
ESGAI Technologies, Inc.
| 4 years |
| Sabas Carrillo | M | 46 | - | |
| Jeffrey Batliner | M | 58 | 4 years | |
| Tiffany Davis | F | 45 | 1 years | |
| Robert Baca | M | 42 | - | |
| Peter D. Eberhart | M | - |
Emory University
| 3 years |
| Stephen Christoffersen | M | 39 | - | |
| Jason Vegotsky | M | 38 | 2 years | |
| Rodrigo de Oliveira | M | 43 | - | |
| Edd Pratt | M | - | - | |
| Christopher Tedford | M | 51 | 2 years | |
| Oren Schauble | M | 39 | 1 years | |
| Italo Andres Zanzi | M | 49 |
Emory University
| 3 years |
| Ira Ritter | M | 75 | 1 years | |
| Alexandra E. Chopin | F | - |
Emory University
| 8 years |
| James McCormick | M | 57 | 2 years | |
| Ben Wu | M | 45 | 4 years | |
| Donald Hunter | M | 67 | - | |
| Ole Frands Sigetty | M | 58 | 5 years | |
| James Miller | M | 63 | - | |
| Edwin Poston | M | 57 |
Emory University
| 4 years |
| Jacob A. Steinfeld | M | - |
Emory University
| 4 years |
| Brent Iloulian | M | - |
Emory University
| 4 years |
| James B. Williams | M | 90 |
Emory University
| 4 years |
| Brad Alford | M | - |
Emory University
| 6 years |
| Clay Manley | M | - |
Emory University
| 2 years |
| Chris Fitze | M | - |
Emory University
| 4 years |
| Kim Kamdar | M | 56 |
Emory University
| 3 years |
| Lijun Sun | M | 61 |
Emory University
| 3 years |
| Brett Gellein | M | - |
Emory University
| 4 years |
| Romesh R. Subramanian | M | 58 |
Emory University
| 3 years |
| Andrew David Vernazza | M | 49 |
Emory University
| 4 years |
| Vincent la Terza | M | - |
Emory University
| 6 years |
| Paul Llewellyn Robertson | M | - |
Emory University
| 2 years |
| Marlon Goldstein | M | 50 |
Emory University
| 4 years |
| Matthew Robert Miller | M | 47 |
Emory University
| 4 years |
| Randall J. Zarin | M | - |
Emory University
| 4 years |
| Peter A. Krivkovich | M | - |
Emory University
| 4 years |
| William Terence Kirby | M | 51 |
Emory University
| 4 years |
| Jonathan Starr | M | 47 |
Emory University
| 4 years |
| Jonathan S. Newpol | M | 65 |
Emory University
| 4 years |
| Harriet Robinson | M | 86 |
Emory University
| 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 67 | 67.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Baum
- Personal Network
